bupropion hydrochloride
- Product NDC
- 47781-637
- 11-digit product format
- 477810637
- Labeler code
- 47781
- Product ID
- 47781-637_ff963f16-8f76-66a6-25aa-fe2020be1fb0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- NDA022497
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2018-09-28
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 450 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47781-637 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [ALVOGEN INC.] | 5 | Legacy NDC | 20240430_a032e7c8-33f2-5fdb-62d7-8517072d1d10.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-637-30 | 47781063730 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30) | 2018-09-28 | 0000-00-00 | No | No | Current |